Ghassemi JahaniSAKarlssonJBrisbyHDanielssonAJ.Health-related quality of life and function in middle-aged individuals with thalidomide embryopathy. J Child Orthop. 2016,
10: 691–703.
2.
HinoshitaFBeppuHShiojiS, et al.
A nationwide survey regarding the life situations of patients with thalidomide embryopathy in Japan, 2018: first report. Birth Defects Res. 2019,
111: 1633–42.
3.
KowalskiTWSanseverinoMTSchuler-FacciniLViannaFS.Thalidomide embryopathy: follow-up of cases born between 1959 and 2010. Birth Defects Res A Clin Mol Teratol. 2015,
103: 794–803.
4.
MarkiewiczMStirlingPBrennanSHooperGLamW.Age-related changes in patients with upper limb thalidomide embryopathy in the United Kingdom. J Hand Surg Eur. Epub ahead of print 6 April 2023. DOI: 10.1177/17531934231164093.
5.
NicotraANewmanCJohnsonM, et al.
Peripheral nerve dysfunction in middle-aged subjects born with thalidomide embryopathy. PLoS One. 2016,
11: e0152902.
6.
NieckeAPetersKMAlayliA, et al.
Health-related quality of life after 50 years in individuals with thalidomide embryopathy: evidence from a German cross-sectional survey. Birth Defects Res. 2022,
114: 714–24.
7.
OshimaYOkutsuIHamanakaIMotomuraT.Carpal tunnel syndrome accompanying radial dysplasia due to thalidomide embryopathy. J Hand Surg Br. 2006,
31: 342–4.
8.
TherapontosCErskineLGardnerERFiggWDVargessonN.Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation. Proc Natl Acad Sci USA. 2009,
106: 8573–8.
